A Case Report on Linezolid and Cefuroxime Induced Leucocytoclastic Vasculitis
1, 2, 1, 1, 1★, 1★ Corresponding author
- 1Department of Pharmacy practice, JSS College of Pharmacy, Mysuru, Jagadguru Shri Shivarathreeshwara Academy of Higher Education and Reasearch, SS Nagar, Mysuru, Karnataka, INDIA.
- 2Department of General Medicine, JSS Medical college and Hospital, JSS Academy of Higher Education and Research, Mysuru, Karnataka, INDIA.
CORRESPONDENCE
Sri Harsha Chalasani
Department of Pharmacy practice, JSS College of Pharmacy, Mysuru, Jagadguru Shri Shivarathreeshwara Academy of Higher Education and Reasearch, SS Nagar, Mysuru, Karnataka, INDIA.
Received: 16-11-2018; Revised: 02-01-2019; Accepted: 17-02-2019.
Volume 11, Issue 2 · pp. 227-229 · 2019 · DOI: 10.5530/jyp.2019.11.47
ABSTRACT
A 65-year-old female diabetic patient with wet gangrene on left great toe developed skin eruptions and blebs over her limbs and lower abdomen after receiving three doses of tablet linezolid + cefuroxime (600mg+500 mg). The skin eruptions and blebs completely resolved fourteen days after discontinuation of tablet Linezolid + Cefuroxime. Based on her presentation (Skin eruptions and blebs), we consider that the condition was a result of linezolid+ cefuroxime administration. While the pathophysiology of these cutaneous reactions is not completely understood, clinicians should be vigilant to allow early detection of these problems. The causality of this adverse reaction was determined by using Naranjo’s criteria and World Health Organization Probability scale and was found to be possible and the severity of this reaction was determined by using the Modified Hartwig and Siegel scale and was found to be moderate (Level 3b) reaction. Although, Linezolid is known to cause dermatological reactions like rashes but the reports of leucocytoclastic vasculitis are rare. Thus, our case report of linezolid + cefuroxime induced leucocytoclastic vasculitis add newer information. Physician should be vigilant for the potential of drug to cause some rare side-effect like leucocytoclastic vasculitis on similar age groups, so that a safer alternative treatment can be started.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Menon, A. R., Kumar, B., Vasavi, K., TS, S., Chalasani, S. H., & Ramesh, M. (2019). A Case Report on Linezolid and Cefuroxime Induced Leucocytoclastic Vasculitis. Journal of Young Pharmacists, 11(2), 227-229. https://doi.org/10.5530/jyp.2019.11.47
Copyright and licence
© 2019 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0